WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental health conditions. Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be … Read more
NEW YORK — It was a landmark moment for the psychedelic movement: The Department of Veteran Affairs’ top doctor stood on stage, praising advocates who have spent decades promoting the healing potential of mind-altering drugs. In an unannounced appearance at a New York psychedelic conference, the VA’s Dr. Shereef Elnahal said his agency was ready … Read more
Specially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study that the researchers hope will help expand options for service members. The U.S. Department of Veterans Affairs provides talk therapy and medications to veterans with post-traumatic stress disorder and runs a pilot program involving service dogs. The VA can … Read more
WASHINGTON — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical mainstream. The panel of advisers to the Food and Drug … Read more
WASHINGTON — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream. The Food and Drug Administration posted its initial review of the drug Friday, … Read more
